ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      4,604.37
      (
      0.41%
      )
      US Tech 100
      15,700.80
      (
      0.54%
      )
      Dow Jones
      36,247.87
      (
      0.36%
      )
      Brent Oil
      75.965
      (
      0.0%
      )
      Bitcoin
      43,786.73
      (
      0.16%
      )
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Gossamer Bio Inc (GOSS)

      7. Gossamer Bio Inc (GOSS) News

      GOSS

      Gossamer Bio (GOSS)

      Gossamer Bio Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:GOSS
      DateTimeSourceHeadlineSymbolCompany
      12/05/20235:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOSSGossamer Bio Inc
      12/05/20235:09PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:GOSSGossamer Bio Inc
      12/05/20234:01PMBusiness WireGossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GOSSGossamer Bio Inc
      12/05/20237:01AMBusiness WireGossamer Bio Appoints Bob Smith as Chief Commercial OfficerNASDAQ:GOSSGossamer Bio Inc
      11/29/20234:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOSSGossamer Bio Inc
      11/29/20237:01AMBusiness WireGossamer Bio Announces Appointment of John Quisel, J.D., Ph.D., to its Board of DirectorsNASDAQ:GOSSGossamer Bio Inc
      11/27/20234:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOSSGossamer Bio Inc
      11/22/20237:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOSSGossamer Bio Inc
      11/22/20237:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOSSGossamer Bio Inc
      11/22/20237:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOSSGossamer Bio Inc
      11/17/20234:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOSSGossamer Bio Inc
      11/14/20236:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOSSGossamer Bio Inc
      11/09/20237:31AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GOSSGossamer Bio Inc
      11/09/20237:31AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOSSGossamer Bio Inc
      11/09/20237:31AMBusiness WireGossamer Bio Announces Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:GOSSGossamer Bio Inc
      10/20/20234:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOSSGossamer Bio Inc
      10/03/20234:08PMBusiness WireGossamer Bio Announces Addition of Rainer Zimmermann, MD, as VP of Medical AffairsNASDAQ:GOSSGossamer Bio Inc
      09/07/20235:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOSSGossamer Bio Inc
      09/07/20237:44AMBusiness WireGossamer Bio to Present Results of TORREY FRI Sub-Study at the European Respiratory Society International Congress 2023NASDAQ:GOSSGossamer Bio Inc
      08/29/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GOSSGossamer Bio Inc
      08/28/20234:29PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:GOSSGossamer Bio Inc
      08/21/20234:01PMEdgar (US Regulatory)Form DEL AM - Delaying amendmentNASDAQ:GOSSGossamer Bio Inc
      08/18/20238:41AMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:GOSSGossamer Bio Inc
      08/18/20238:38AMEdgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:GOSSGossamer Bio Inc
      08/17/20234:01PMEdgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:GOSSGossamer Bio Inc
      08/08/20234:03PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GOSSGossamer Bio Inc
      08/08/20234:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOSSGossamer Bio Inc
      08/08/20234:01PMBusiness WireGossamer Bio Announces Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:GOSSGossamer Bio Inc
      08/07/20234:44PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:GOSSGossamer Bio Inc
      07/28/20233:46PMEdgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:GOSSGossamer Bio Inc
       Showing the most relevant articles for your search:NASDAQ:GOSS